A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases

• Published in: International journal of molecular sciences Vol. 25; no. 7; p. 3564
• Main Authors: Petrović, Stanko, Tarabar, Dino, Ćujić, Danica, Stamenkovic, Dusica, Petrović, Marijana, Rančić, Nemanja, Subota, Vesna, Perišić, Nenad, Bezmarević, Mihailo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2024
• Subjects: Analysis; Anemia; Anemia - diagnosis; Anemia - etiology; Biomarkers; Chronic diseases; Complications and side effects; Crohn’s disease; Cytokines; Disease; Ethylenediaminetetraacetic acid; Ferritin; Ferritins; Hemoglobin; hepcidin; Hepcidins; Homeostasis; Humans; Inflammation; Inflammatory bowel disease; Inflammatory Bowel Diseases - complications; Inflammatory Bowel Diseases - diagnosis; Interleukins; Iron; Medical research; Medicine, Experimental; Patients; Prospective Studies; Remission (Medicine); Ulcerative colitis; Serbia; Taiwan; cytokine; ferritin; hepcidin; inflammation; ulcerative colitis; anemia; Crohn’s disease
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25073564

Iron deficiency (IDA) and chronic disease (ACD) anemia are complications of inflammatory bowel diseases (IBDs). Therapeutic modalities in remission and active IBD depend on the type of anemia. This study evaluated the link between hepcidin-25, proinflammatory cytokines, and platelet activation markers as biomarkers of anemia and inflammation in active IBD and remission. This prospective observational study included 62 patients with IBD (49 with ulcerative colitis and 13 with Crohn's) and anemia. Patients were divided into Group I (no or minimal endoscopic signs of disease activity and IDA), Group II (moderate and major endoscopic signs of disease activity and mild ACD), and Control group (10 patients with IBD in remission, without anemia). We assessed the difference among groups in the levels of CRP, hemoglobin (Hgb), serum iron, ferritin, hepcidin-25, interleukins, TNF-α, IFN-γ, soluble CD40 ligand, and sP-selectin. Hepcidin-25 levels were significantly higher in Group II versus Group I (11.93 vs. 4.48 ng/mL, < 0.001). Ferritin and CRP values showed similar patterns in IBD patients: significantly higher levels were observed in Group II (47.5 ng/mL and 13.68 mg/L) than in Group I (11.0 ng/mL and 3.39 mg/L) ( < 0.001). In Group II, hepcidin-25 was positively correlated with ferritin (ρ = 0.725, < 0.001) and CRP (ρ = 0.502, = 0.003). Ferritin was an independent variable influencing hepcidin-25 concentration in IBD patients, regardless of disease activity and severity of anemia. IBD hepcidin-25 best correlates with ferritin, and both parameters reflected inflammation extent and IBD activity.